Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FHPYS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,664
Award facts
- Contract value 100% obligated
- $33,664.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,664.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, issued on June 5, 2025, with an ultimate completion date of June 6, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains.
ENBREL (etanercept) is a biologic immunosuppressant used to treat autoimmune conditions including rheumatoid arthritis, and the SureClick delivery system represents a pre-filled, single-dose auto-injector formulation. This award demonstrates AmerisourceBergen's ongoing role in supplying specialty pharmaceuticals and biologics to support Department of Defense medical supply chain requirements. The DLA Medical Supply Chain relies on such pharmaceutical prime vendor arrangements to ensure timely access to critical medications for military personnel and beneficiaries, with DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions to maintain competitive supplier diversity.
Quick answers
Who was awarded contract SPE2DB25FHPYS?
SPE2DB25FHPYS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FHPYS worth?
The government has obligated $33,664 on SPE2DB25FHPYS.
Is contract SPE2DB25FHPYS an order under another contract?
Yes. SPE2DB25FHPYS is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHPYS competed?
The extent of competition for SPE2DB25FHPYS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award